Overview

Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy of STW5 Iberogast, over a 28-day period, for the treatment of constipation in parkinsonian patients suffering from gastrointestinal disorders.
Phase:
Phase 2
Details
Lead Sponsor:
Nantes University Hospital